AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25496674 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (5 ml of 0.9% saline)
Number of subjects: 99
Study 23583022 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphasia group
Number of subjects: 14
Study 23583022 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 23583022 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 21451755 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based educational experience
Number of subjects: 82
Study 19373224 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low carbohydrate, high fat (LC) diet
Number of subjects: 60
Study 19373224 — intervention group
Group type: COMPARATOR
Intervention: Conventional high carbohydrate, low fat (HC) diet
Number of subjects: 60
Study 19373224 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 60
Study 16439498 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer and coaching
Number of subjects: 57
Study 16439498 — intervention group
Group type: COMPARATOR
Intervention: Coaching-only
Number of subjects: 57
Study 16439498 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pedometer and coaching, coaching-only)
Number of subjects: 57
Study 11865969 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (110, 220, 330, or 440 microg bid)
Number of subjects: 153
Study 11865969 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide (500 microg or 1000 microg bid)
Number of subjects: 153
Study 11865969 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary cortisol measurement
Number of subjects: 153
Study 11865969 — intervention group
Group type: COMPARATOR
Intervention: Control regimens (prednisone or placebo)
Number of subjects: 153
Study 10036950 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg bid + Amoxicillin 500 mg qid + Clarithromycin 400 mg bid (OAC)
Number of subjects: 234
Study 10036950 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg bid + Clarithromycin 400 mg bid (OC)
Number of subjects: 234
Study 8819747 — intervention group
Group type: EXPERIMENTAL
Intervention: Low structured sequence
Number of subjects: 0
Study 8819747 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 8819747 — intervention group
Group type: EXPERIMENTAL
Intervention: High structured sequence
Number of subjects: 0
Study 2183719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (800 mg oral dose)
Number of subjects: 143
Study 2183719 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (3 g) plus Probenecid (1 g)
Number of subjects: 143
Study 7401203 — intervention group
Group type: EXPERIMENTAL
Intervention: Washed red cell concentrates
Number of subjects: 2
Study 7401203 — intervention group
Group type: COMPARATOR
Intervention: Unwashed red cell concentrates
Number of subjects: 2
Study 7401203 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (washed and unwashed)
Number of subjects: 2
Study 6601746 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg . kg‐1 lidoflazine intravenously before cardiopulmonary bypass (CPB)
Number of subjects: 0
Study 6601746 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg . kg‐1 lidoflazine intravenously before cardiopulmonary bypass (CPB)
Number of subjects: 0
Study 6601746 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lidoflazine)
Number of subjects: 0
Study 30465720 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Generated Index (PGI)
Number of subjects: 33
Study 30465720 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia criteria (2016 modified criteria)
Number of subjects: 33
Study 30465720 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Fatigue Syndrome criteria (Canada criteria)
Number of subjects: 33
Study 30465720 — intervention group
Group type: EXPERIMENTAL
Intervention: Bodily Distress Syndrome (multi-organ type)
Number of subjects: 33
Study 30465720 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia criteria (2011 and 2010 criteria)
Number of subjects: 33
Study 29396758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide
Number of subjects: 12
Study 27310976 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 25
Study 24661681 — intervention group
Group type: EXPERIMENTAL
Intervention: Lokomat training (12 sessions of 1 hour each over one month)
Number of subjects: 40
Study 24661681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interventions)
Number of subjects: 40
Study 22055480 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin‐mineral supplement
Number of subjects: 58
Study 20458640 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly crosslinked polyethylene (HXLP)
Number of subjects: 122
Study 20458640 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyethylene
Number of subjects: 122
Study 18096536 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided detection (CAD) as second reader
Number of subjects: 60
Study 18096536 — intervention group
Group type: COMPARATOR
Intervention: Control group (without CAD)
Number of subjects: 60
Study 15921804 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo-Doppler
Number of subjects: 366
Study 15921804 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic decision-making based on echo-Doppler findings
Number of subjects: 366
Study 12051127 — intervention group
Group type: EXPERIMENTAL
Intervention: All-ceramic 3-unit bridges
Number of subjects: 48
Study 12051127 — intervention group
Group type: COMPARATOR
Intervention: Porcelain-fused-to-metal bridges
Number of subjects: 48
Study 10340839 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for isolated systolic hypertension; specific intervention details not provided.
Number of subjects: 0
Study 10340839 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure control in patients with diastolic hypertension; specific intervention details not provided.
Number of subjects: 0
Study 11324827 — intervention group
Group type: EXPERIMENTAL
Intervention: reverse transcriptase inhibitors (zidovudine or didanosine monotherapy or alternating zidovudine and didanosine)
Number of subjects: 47
Study 1917502 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood team model
Number of subjects: 0
Study 7153153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.25 mg
Number of subjects: 7
Study 7153153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.5 mg
Number of subjects: 7
Study 7153153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 1.0 mg
Number of subjects: 7
Study 7153153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 3.0 mg
Number of subjects: 7
Study 7153153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 6.0 mg
Number of subjects: 7
Study 7153153 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 7
Study 31927325 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BP level
Number of subjects: 961
Study 31927325 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BP variability
Number of subjects: 961
Study 31927325 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater diastolic BP variability
Number of subjects: 961
Study 30238444 — intervention group
Group type: EXPERIMENTAL
Intervention: Early endovenous ablation of superficial venous reflux within 2 weeks after randomization
Number of subjects: 450
Study 30238444 — intervention group
Group type: COMPARATOR
Intervention: Deferred endovenous ablation of superficial venous reflux, with compression therapy alone
Number of subjects: 450
Study 30132361 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered monitoring visits
Number of subjects: 42
Study 30132361 — intervention group
Group type: COMPARATOR
Intervention: Untriggered monitoring visits
Number of subjects: 42
Study 30132361 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered monitoring visits (excluding re-consent findings)
Number of subjects: 42
Study 30132361 — intervention group
Group type: COMPARATOR
Intervention: Untriggered monitoring visits (excluding re-consent findings)
Number of subjects: 42
Study 26800087 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedge
Number of subjects: 26
Study 26800087 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedge plus arch support
Number of subjects: 26
Study 26800087 — intervention group
Group type: COMPARATOR
Intervention: Control (no orthotic)
Number of subjects: 26
Study 24503784 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg once daily for ≈4 weeks)
Number of subjects: 19
Study 24503784 — intervention group
Group type: COMPARATOR
Intervention: Control (oral hypoglycemic agents)
Number of subjects: 19
Study 24837018 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy motivation (incentive) with 95% anchor
Number of subjects: 0
Study 24837018 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy motivation (incentive) with 55% anchor
Number of subjects: 0
Study 24837018 — intervention group
Group type: COMPARATOR
Intervention: No accuracy motivation with 95% anchor
Number of subjects: 0
Study 24837018 — intervention group
Group type: COMPARATOR
Intervention: No accuracy motivation with 55% anchor
Number of subjects: 0
Study 24837018 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy motivation (no incentive) with 95% anchor
Number of subjects: 0
Study 24837018 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy motivation (no incentive) with 55% anchor
Number of subjects: 0
Study 20703162 — intervention group
Group type: EXPERIMENTAL
Intervention: ER + PC mode
Number of subjects: 21
Study 20703162 — intervention group
Group type: COMPARATOR
Intervention: Conventional PC mode
Number of subjects: 21
Study 17575561 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Tramadol Contramid OAD tablet
Number of subjects: 27
Study 17575561 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg Tramadol Contramid OAD tablet
Number of subjects: 27
Study 17575561 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg Tramadol Contramid OAD tablet
Number of subjects: 27
Study 15694088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg)
Number of subjects: 60
Study 15694088 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular 15‐methyl‐prostaglandin F2alpha (125 microg)
Number of subjects: 60
Study 11866001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 921
Study 11866001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 10532693 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment with high doses of lovastatin (40-80 mg/day)
Number of subjects: 0
Study 10532693 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate treatment with low doses of lovastatin (2.5-5 mg/day)
Number of subjects: 0
Study 10532693 — intervention group
Group type: COMPARATOR
Intervention: Low dose warfarin
Number of subjects: 0
Study 7766739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily for 4 weeks
Number of subjects: 219
Study 7766739 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily for 4 weeks
Number of subjects: 219
Study 7766739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg after 8 weeks
Number of subjects: 219
Study 7766739 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg after 8 weeks
Number of subjects: 219
Study 7766739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg after 2 weeks for patients with ulcer pain
Number of subjects: 219
Study 7766739 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg after 2 weeks for patients with ulcer pain
Number of subjects: 219
Study 7766739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg after 4 weeks for patients with ulcer pain
Number of subjects: 219
Study 7766739 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg after 4 weeks for patients with ulcer pain
Number of subjects: 219
Study 7766739 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 219
Study 2308462 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mW helium neon continuous-wave (0.633 microns) laser irradiation
Number of subjects: 40
Study 2308462 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 6998274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose diet (30% of calories as sucrose)
Number of subjects: 19
Study 6998274 — intervention group
Group type: COMPARATOR
Intervention: Starch diet (30% of calories as wheat starch)
Number of subjects: 19
Study 6998274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose diet after 6 weeks
Number of subjects: 19
Study 6998274 — intervention group
Group type: COMPARATOR
Intervention: Starch diet after 6 weeks
Number of subjects: 19
Study 31996174 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 126
Study 31996174 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention support group (Control)
Number of subjects: 126
Study 31289056 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Adjustment Coping Intervention (PACI) - daily text messages with positive-adjustment coping attitudes
Number of subjects: 0
Study 31289056 — intervention group
Group type: COMPARATOR
Intervention: Cognitive distractions - daily text messages with cognitive distractions
Number of subjects: 0
Study 31289056 — intervention group
Group type: EXPERIMENTAL
Intervention: PACI
Number of subjects: 0
Study 31289056 — intervention group
Group type: COMPARATOR
Intervention: Cognitive distractions
Number of subjects: 0
Study 27003945 — intervention group
Group type: COMPARATOR
Intervention: EDSS-Plus
Number of subjects: 215
Study 27003945 — intervention group
Group type: COMPARATOR
Intervention: EDSS
Number of subjects: 215
Study 27003945 — intervention group
Group type: COMPARATOR
Intervention: T25FW
Number of subjects: 215
Study 27003945 — intervention group
Group type: COMPARATOR
Intervention: 9HPT (either hand)
Number of subjects: 215
Study 27003945 — intervention group
Group type: EXPERIMENTAL
Intervention: 9HPT (dominant hand)
Number of subjects: 215
Study 27003945 — intervention group
Group type: EXPERIMENTAL
Intervention: 9HPT (non-dominant hand)
Number of subjects: 215
Study 24750784 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional resistance training
Number of subjects: 35
Study 24750784 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic training
Number of subjects: 35
Study 24750784 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study 23149383 — intervention group
Group type: EXPERIMENTAL
Intervention: Volitional pursed lips breathing (PLB) during 6-minute walk test (6MWT)
Number of subjects: 0
Study 23149383 — intervention group
Group type: EXPERIMENTAL
Intervention: Volitional pursed lips breathing (PLB)
Number of subjects: 0
Study 22218098 — intervention group
Group type: EXPERIMENTAL
Intervention: Active blood pressure lowering treatment (indapamide SR 1.5 mg plus perindopril 2-4 mg if required)
Number of subjects: 1712
Study 19501764 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast cereals (specific types not mentioned)
Number of subjects: 0
Study 16869334 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial Trial Intervention (STI)
Number of subjects: 114
Study 16869334 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses using STI
Number of subjects: 114
Study 16869334 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological comfort treatments
Number of subjects: 114
Study 16869334 — intervention group
Group type: COMPARATOR
Intervention: Nonpharmacological comfort treatments
Number of subjects: 114
Study 14516240 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual plus group counseling for cocaine dependence
Number of subjects: 0
Study 14516240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 10636264 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (15 mg in 30 min, stopped 5 min before testing)
Number of subjects: 10
Study 10636264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8811376 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral intake (Group I) allowed ab libitum intake of clear liquids starting the first evening after the operation, progressing to a regular diet on the first postoperative day.
Number of subjects: 190
Study 8811376 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral intake (Group I)
Number of subjects: 190
Study 8811376 — intervention group
Group type: COMPARATOR
Intervention: Control (Group II) with nasogastric tube removed when postoperative ileus resolved.
Number of subjects: 190
Study 8811376 — intervention group
Group type: COMPARATOR
Intervention: Control (Group II)
Number of subjects: 190
Study 1389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (n = 85)
Number of subjects: 255
Study 1389851 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine (n = 85)
Number of subjects: 255
Study 1389851 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Saline) (n = 85)
Number of subjects: 255
Study 2865518 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mefloquine and sulfadoxine/pyrimethamine
Number of subjects: 36
Study 2865518 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine/pyrimethamine
Number of subjects: 36
Study 29859849 — intervention group
Group type: EXPERIMENTAL
Intervention: D-amp 10mg
Number of subjects: 95
Study 29859849 — intervention group
Group type: EXPERIMENTAL
Intervention: D-amp 20mg
Number of subjects: 95
Study 29859849 — intervention group
Group type: EXPERIMENTAL
Intervention: D-amp 0.3 mg/kg
Number of subjects: 95
Study 29859849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 29859849 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 95
Study 27572344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (15 sessions, daily 30 min)
Number of subjects: 22
Study 27572344 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy (same amount as experimental group)
Number of subjects: 22
Study 26112041 — intervention group
Group type: EXPERIMENTAL
Intervention: BALANCE intervention
Number of subjects: 1325
Study 26112041 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1325
Study 23011680 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg prednisone daily with methotrexate-based tight control strategy
Number of subjects: 0
Study 23011680 — intervention group
Group type: COMPARATOR
Intervention: Placebo with methotrexate-based tight control strategy
Number of subjects: 0
Study 23011680 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (prednisone and placebo)
Number of subjects: 0
Study 22083987 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 81
Study 22083987 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 81
Study 22083987 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 81
Study 18925394 — intervention group
Group type: EXPERIMENTAL
Intervention: Four hour clamping drainage
Number of subjects: 60
Study 18925394 — intervention group
Group type: COMPARATOR
Intervention: Conventional suction drainage
Number of subjects: 60
Study 16365721 — intervention group
Group type: EXPERIMENTAL
Intervention: Oily calcium hydroxide suspension (OCHS) with access flap surgery (AFS)
Number of subjects: 30
Study 16365721 — intervention group
Group type: COMPARATOR
Intervention: Access flap surgery (AFS) alone
Number of subjects: 30
Study 14628976 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (200 mg/day)
Number of subjects: 966
Study 14628976 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (0.8-1.1 mEq/L)
Number of subjects: 966
Study 14628976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 966
Study 14628976 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 966
Study 14628976 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 966
Study 11134101 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT+F (75 g glucose + 7.5 g fructose)
Number of subjects: 11
Study 11134101 — intervention group
Group type: COMPARATOR
Intervention: OGTT‐F (75 g glucose without fructose)
Number of subjects: 11
Study 11134101 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT+F
Number of subjects: 11
Study 11134101 — intervention group
Group type: COMPARATOR
Intervention: OGTT‐F
Number of subjects: 11
Study 9075447 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse counseling intervention using the Eating Pattern Assessment Tool and brand-specific food advice; up to 5 counseling visits in the initial study.
Number of subjects: 135
Study 9075447 — intervention group
Group type: COMPARATOR
Intervention: Nurse counseling intervention (same as above); patients attending 2 or more counseling sessions matched with other patients.
Number of subjects: 135
Study 8277075 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin plus N-acetylcysteine (0.1 microgram/kg per min + 2 g intravenously, followed by 5 mg/kg per h)
Number of subjects: 8
Study 8277075 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin plus placebo (0.1 microgram/kg per min)
Number of subjects: 8
Study 8277075 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin plus N-acetylcysteine
Number of subjects: 8
Study 2929629 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg PPA
Number of subjects: 16
Study 2929629 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg PPA plus 400 mg caffeine
Number of subjects: 16
Study 2929629 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg PPA
Number of subjects: 16
Study 2929629 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg caffeine
Number of subjects: 16
Study 2929629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 29703040 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) at ST36-ST37, 20 minutes twice a day for 5 days
Number of subjects: 82
Study 29703040 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapies (control group)
Number of subjects: 82
Study 28396238 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose low molecular weight heparin (LMWH) combined with graduated compression stockings (GCS)
Number of subjects: 2236